Welcome to our dedicated page for Jpmorgan Chase SEC filings (Ticker: JPM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The JPMorgan Chase & Co. (NYSE: JPM) SEC filings page on Stock Titan provides access to the firm’s regulatory disclosures as a leading financial services company based in the United States with operations worldwide. Through these filings, investors can review how the firm reports on its commercial banking, consumer and small business services, corporate and investment banking, financial transaction processing and asset and wealth management activities.
Current and periodic reports such as Form 8-K detail material events, earnings announcements, capital markets transactions and governance changes. Recent 8-K filings include information on quarterly financial results, investor presentations reviewing earnings, public offerings of fixed-to-floating rate notes and the resignation of a member of the Board of Directors. These documents help investors track developments affecting JPMorgan Chase’s capital structure, funding and leadership.
Filings also list the securities registered under Section 12(b) of the Securities Exchange Act. JPMorgan Chase’s common stock trades on the New York Stock Exchange under the symbol JPM. The firm has multiple series of non-cumulative preferred stock represented by depositary shares, each trading under its own symbol, and it guarantees certain notes and exchange-traded notes issued by JPMorgan Chase Financial Company LLC that are listed on the New York Stock Exchange and NYSE Arca.
On Stock Titan, these SEC filings are updated from the EDGAR system and paired with AI-powered summaries that explain key points in clear language. Investors can use this page to quickly understand the implications of earnings releases (Form 8-K items on results of operations), capital markets activity, preferred stock and note offerings, and other corporate events disclosed in JPMorgan Chase’s regulatory reports, without reading every line of the underlying documents.
JPMorgan Chase director Brad D. Smith reported a deferred stock award under the company’s director compensation program. On 01/20/2026, he was credited with 913.5251 shares of common stock at a price of $306.505 per share, described as a deferral of his annual stock grant payable in shares upon termination of his service as a director. Following this transaction, he directly beneficially owned 2,946.5824 shares. The filing also lists additional indirect holdings in JPMorgan Chase common stock through family trusts, his spouse, a spouse’s GRAT, and a spouse’s IRA.
JPMorgan Chase director Alex Gorsky reported a deferred stock grant from his board service. On 01/20/2026, he acquired 913.5251 shares of JPMorgan Chase common stock at a reported price of $306.505 per share. According to the filing, this was a deferral of his annual stock grant, which will be payable in shares of stock upon termination of his service as a director.
Following this transaction, Gorsky beneficially owned 7,293.5825 shares of JPMorgan Chase common stock in direct form. The transaction reflects routine director compensation rather than an open-market purchase or sale.
JPMorgan Chase director Melody L. Hobson reported receipt of 913.5251 shares of common stock on January 20, 2026, coded as an acquisition. The footnote explains this is a deferral of her annual stock grant, which will be paid in JPM shares when her service as a director ends.
After this transaction, Hobson beneficially owned 29,552.0067 shares directly and 124,155 shares indirectly through The GWL Living Trust. This filing reflects routine director equity compensation and updated ownership levels.
JPMorgan Chase director Alicia Boler Davis reported receiving a deferred annual stock grant tied to her board service. On 01/20/2026, she acquired 913.5251 shares of common stock at $306.505 per share through a transaction coded as an acquisition. After this grant, she held 3,611.4062 shares of JPMorgan Chase common stock directly, and an additional 285 shares held indirectly by a trust. The filing explains that this represents a deferral of her annual stock grant, which will be payable in JPMorgan Chase shares upon the termination of her service as a director.
JPMorgan Chase director Stephen B. Burke reported a deferred stock award related to his board service. On 01/20/2026, he accrued 913.5251 shares of common stock at $306.505 per share as a deferral of his annual stock grant, which will be paid in JPM shares when his service as a director ends. Following this transaction, he beneficially owns 207,151.8098 shares of JPM common stock directly. He also reports indirect beneficial ownership of 55,245 shares held by a GRAT.
JPMorgan Chase director Linda Bammann reported an acquisition of JPM common stock tied to her board compensation. On January 20, 2026, she acquired 913.5251 shares of common stock at $306.505 per share, described as a deferral of her annual stock grant that will be paid in JPM shares when her service as a director ends. After this transaction, she directly beneficially owns 83,455.079 shares of JPMorgan Chase common stock. The filing does not list any derivative securities transactions.
JPMorgan Chase reported an equity award to Corporate Controller Elena A. Korablina in the form of 8,157 Restricted Stock Units (RSUs) on January 20, 2026. Each RSU represents a contingent right to receive one share of JPMorgan Chase common stock and was recorded at an exercise price of $0.0000 per unit.
The RSUs vest in two equal tranches, with 50% scheduled to vest on January 13, 2028 and the remaining 50% on January 13, 2029. These equity incentives are subject to the firm’s Bonus Recoupment Policy, 2026 award recapture provisions, and additional protection-based vesting terms that allow the firm to cancel or recover awards in specified circumstances.
JPMorgan Chase Co-CEO of CIB Troy L. Rohrbaugh reported an award of 25,938 Restricted Stock Units (RSUs) on January 20, 2026. Each RSU represents a contingent right to receive one share of JPMorgan Chase common stock, and all 25,938 derivative securities are shown as directly owned after the transaction.
The RSUs relate to performance year 2025, where RSUs make up 50% of his equity-based incentive compensation and the remaining 50% is in Performance Share Units. The RSUs vest in two equal installments: 50% on January 13, 2028 and 50% on January 13, 2029.
The award is subject to the firm’s Bonus Recoupment Policy in the event of a material restatement of financial statements, as well as recapture provisions that allow cancellation or recovery of value in specified circumstances. Portions of equity awards to Operating Committee members are also subject to Protection-based Vesting, which can lead to cancellation, subject to ratification by the Board’s Compensation & Management Development Committee.
JPMorgan Chase & Co. (JPM) Chief Operating Officer Jennifer Piepszak reported an equity award of 21,289 Restricted Stock Units (RSUs) dated January 20, 2026. Each RSU represents a contingent right to receive one share of JPMC common stock. For performance year 2025, RSUs represent 50% of her equity-based incentive compensation, with the remaining 50% awarded as Performance Share Units.
The RSUs vest in two equal installments, with 50% vesting on January 13, 2028 and 50% on January 13, 2029. These equity incentives are subject to JPMorgan Chase’s Bonus Recoupment Policy in the event of a material restatement of financial statements, as well as recapture provisions that allow the firm to cancel outstanding awards or recover stock value in specified circumstances. Portions of equity awards granted to Operating Committee members are also subject to additional Protection-Based Vesting provisions that may result in cancellation, subject to Compensation & Management Development Committee ratification.
JPMorgan Chase reported an equity award to senior executive Leopold Robin, Head of Human Resources. On January 20, 2026, Robin received 8,565 Restricted Stock Units (RSUs) at a price of $0.0000 per unit, reflecting part of his equity-based incentive compensation for performance year 2025.
Each RSU represents a contingent right to receive one share of JPMorgan Chase common stock. The RSUs vest in two equal installments, with 50% vesting on January 13, 2028 and 50% on January 13, 2029. These equity incentives are subject to the firm’s bonus recoupment and recapture provisions, and, for Operating Committee members, additional protection-based vesting conditions that can lead to cancellation or recovery of awards in specified circumstances.